Eviso Injection
Eviso – Iron Isomaltoside Injection / Infusion 5ml (100mg/ml)
- Increases mean HB level in NDD-CKD patients by 1.2g/dL in single bolus injection /week.
- Maintains HB level between 9.5 – 12.g/dL in dialysis dependent CKD patients.
- Significant increase in transferrin saturation and ferritin levels.
- Substantially lower risk of hyperphosphatemia compared to FCM.
Description
Eviso – Iron Isomaltoside Injection / Infusion 5ml (100mg/ml)
- Increases mean HB level in NDD-CKD patients by 1.2g/dL in single bolus injection /week.
- Maintains HB level between 9.5 – 12.g/dL in dialysis dependent CKD patients.
- Significant increase in transferrin saturation and ferritin levels.
- Substantially lower risk of hyperphosphatemia compared to FCM.
Be the first to review “Eviso Injection”
Reviews
There are no reviews yet.